ArticleThe journal of allergy and clinical immunology. Global2025

Tezepelumab achieves improvement of severe uncontrolled asthma and rhinosinusitis: Case series.

Shigesato Inoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.